Compounds > olmesartan medoxomil
Page last updated: 2024-09-03

olmesartan medoxomil and Atrophy

olmesartan medoxomil has been researched along with Atrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Gabb, GM; Moore, K; Shukla, N1
Janssen, J; Mulder, CJ; Nijeboer, P; van Beurden, YH; Verbeek, WH1
Gonzalo, DH; Martelli, MG; Naik, DK; Pannu, D; Sharma, AK1

Other Studies

3 other study(ies) available for olmesartan medoxomil and Atrophy

ArticleYear
Olmesartan-associated duodenal villous atrophy, an emerging clinical issue.
    Internal medicine journal, 2020, Volume: 50, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles

2020
[Diarrhoea and malabsorption due to olmesartan use].
    Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158

    Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Humans; Hypertension; Imidazoles; Male; Middle Aged; Netherlands; Olmesartan Medoxomil; Tetrazoles

2014
An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
    BMJ case reports, 2015, Sep-14, Volume: 2015

    Topics: Aged, 80 and over; Atrophy; Celiac Disease; Diarrhea; Female; Humans; Imidazoles; Intestinal Diseases; Intestines; Olmesartan Medoxomil; Tetrazoles

2015